Background
==========

Although there is evidence that the prevalence of childhood obesity is stabilising at different levels in different countries \[[@B1]\], the number of children and adolescents being overweight or obese is still dramatically high \[[@B2],[@B3]\]. The major concern is that these children are at high risk of developing severe co-morbidities such as metabolic syndrome, non-alcohol fatty liver disease, type 2 diabetes mellitus and premature cardiovascular diseases \[[@B4],[@B5]\]. Moreover, obese children are highly prone to become obese adults, especially when having a high body mass index (BMI) or an obese parent \[[@B6],[@B7]\]. In order to combat childhood obesity and related complications, prevention is crucial. At the moment, the most important strategies to manage childhood obesity are therapeutic lifestyle changes, such as changing dietary habits and the physical activity level. However, these are often difficult to achieve. When lifestyle modifications continue to fail, pharmacological interventions and possibly bariatric surgery could be considered.

Nowadays, it is generally accepted that the development of obesity is caused by gene-environment interactions, generating a chronic positive energy balance \[[@B8]\]. However, physiological and environmental predispositions underlying obesity and associated metabolic disorders are still underexplored. Recent evidence suggests that our gut microbiota is involved in energy regulation as well as inflammation \[[@B9]\], and should therefore be considered as an environmental factor playing a role in the pathophysiology of obesity \[[@B10],[@B11]\]. Although energy intake can affect the gut microbiota composition \[[@B12]\], it is still unclear whether the gut microbiota play a causal role in the development of obesity in humans.

So far, several studies in humans and mice have shown differences in gut microbiota composition between obese and lean subjects. These differences were mostly detected at the phylum level of mainly Firmicutes and Bacteroidetes \[[@B11]-[@B14]\]. Obesity in humans has already been associated with low intestinal concentrations of Bacteroidetes and high concentrations of Firmicutes, although this finding has been contradicted by other studies \[[@B15],[@B16]\]. Only few studies have investigated the prevalence of faecal bacterial phyla in obese children and adolescents. One study demonstrated low concentrations of Bacteroidetes and high concentrations of Firmicutes in the distal gut of obese adolescents living in Spain \[[@B17]\]. Another study in Sweden, did not find significant differences in the concentrations of *Bacteroides fragilis* group, *Lactobacillus* spp. and *Bifidobacterium* spp. between preschool children with excessive body weight and normal-weight children \[[@B18]\]. By contrast, Vael et al. \[[@B19]\] demonstrated that a high intestinal concentration of *Bacteroides fragilis* group present in early infancy was associated with a higher risk of obesity later in life. In general, limited and contradictory findings with regard to the composition of the gut microbiota in obese children indicate that further in-depth analysis of the role of the intestinal microbiota in childhood obesity is warranted.

The principal aim of this study is to evaluate and compare the presence of certain gut bacterial species in faecal samples of obese and lean children and adolescents. Quantitative culturing was used to identify and determine the concentrations of the following bacterial genera: *Bacteroides fragilis* group, *Bifidobacterium*, *Clostridium*, *Staphylococcus* and *Lactobacillus*. In addition to quantitative culturing, matrix-assisted laser desorption/ionization mass spectrometry (MALDI-TOF MS) was used for in-depth analysis of species belonging to the *Bacteroides fragilis* group. Quantitative real-time polymerase chain reaction (qPCR) was applied to quantify *Bacteroides-Prevotella-Porphyromonas* spp.*, Bifidobacterium* spp.*, Clostridium coccoides-Eubacterium rectale* group*, Clostridium leptum* group*, Staphylococcus* spp. and *Lactobacillus* spp. The Firmicutes-to-Bacteroidetes ratio was calculated based on the qPCR results. Finally, analysed gut bacterial species were associated with dietary compounds and energy intake, which were assessed by dietary records. Moreover, concentrations of biochemical blood parameters were measured in overweight and obese subjects.

Results
=======

Subject characteristics
-----------------------

Characteristics of the study population are shown in Table  [1](#T1){ref-type="table"}. In total, 9 overweight, 7 obese, 10 morbidly obese (O/O) children and 21 normal-weight, 5 thinness grade I and 1 thinness grade III (C) children were included (see Methods section for details on BMI classification). Age, gender, height and dietary intake were not significantly different between the two study groups.

###### 

General characteristics of the studied population

                             **O/O (n = 26)**     **C (n = 27)**     **p value**
  ------------------------- ------------------- ------------------- -------------
  **Anthropometric data**                                                  
  Gender (F/M), n                  12/14               11/16            0.691
  Age, y                       11.64 ± 2.43        10.70 ± 3.12         0.229
  Height, cm                   153.6 ± 15.7        144.7 ± 18.6         0.063
  Weight, kg                    69.8 ± 25.1         35.7 ± 12.6      \< 0.0001\*
  BMI, kg/m^2^                 28.73 ± 6.53        16.48 ± 2.10      \< 0.0001\*
  BMI SDS                       2.69 ± 0.80        −0.43 ± 0.96      \< 0.0001\*
  **Dietary data**                                                  
  Number, n                         22                  25                 
  Energy, kcal/d             2 231.95 ± 437.69   2 082.32 ± 446.79      0.254
  Carbohydrates, en%           45.68 ± 9.55        48.81 ± 6.28         0.199
  Fat, en%                     40.08 ± 9.73        38.59 ± 6.01         0.537
  Protein, en%                 14.43 ± 3.94        14.48 ± 6.54         0.976
  Dietary fibre, g/d           19.26 ± 8.33        15.64 ± 7.33         0.120

O/O: obese group; C: control group; BMI SDS: body mass index standard deviation score. \*Significant differences with p value \< 0.05.

Quantification of bacterial genera and species of *Bacteroides fragilis* group
------------------------------------------------------------------------------

Differences in the concentrations of bacterial genera between O/O and C children are presented in Figure  [1](#F1){ref-type="fig"}A, B and C. Figure  [1](#F1){ref-type="fig"}A illustrates differences between gut microbiota in O/O and C children detected by quantitative plating. *Bacteroides fragilis* group and *Clostridium* spp. were borderline, but non-significantly different between O/O and C children (5.69 ± 2.14 vs. 6.66 ± 0.84 and 5.94 ± 1.10 vs. 6.31 ± 0.80, respectively; p = 0.050 and p = 0.074). In-depth analysis of species belonging to the *Bacteroides fragilis* group using MALDI-TOF MS revealed dominating relative proportions of *B. fragilis* (17.3% vs. 6.1%, p = 0.136) and *B. thetaiotaomicron* (11.5% vs. 7.5%, p = 0.930) in faecal samples of O/O children compared with C children (Figure  [1](#F1){ref-type="fig"}B). By contrast, in C children, relative proportions of *B. caccae* (10.7% vs. 4.0%, p = 0.051), *B. ovatus* (9.3% vs. 7.6%, p = 0.585), *B. uniformis* (6.3% vs. 1.5%, p = 0.177) and *B. vulgatus* (21.7% vs. 6.2%, p = 0.004) prevailed. Note that only *B. vulgatus* proportions were significantly different between the O/O and C children. Figure  [1](#F1){ref-type="fig"}C shows differences found between gut bacterial species in O/O and C children detected by qPCR. In contrast to the quantitative plating results, faecal concentrations of *Lactobacillus* spp. were found to be significantly higher in O/O compared with C children and adolescents (6.44 ± 1.20 vs. 5.69 ± 1.80, p = 0.035) using qPCR.

![**Differences in bacterial genera between O/O and C group. A**: Differences in bacterial genera between O/O and C detected by quantitative plating. **B**: Differences in relative proportions of *Bacteroides fragilis* group species between O/O and C detected by MALDI-TOF MS. **C**: Differences in bacterial genera between O/O and C detected by qPCR. Data of quantitative plating and qPCR are expressed as mean log~10~ cells/g of faeces. Data of MALDI-TOF MS are reported in percentages (%). O/O: obese group; C: control group. Error bars 95% CI. \*\*p = 0.004. \*p = 0.04.](1757-4749-5-10-1){#F1}

The Firmicutes-to-Bacteroidetes ratio
-------------------------------------

In Figure  [2](#F2){ref-type="fig"}, a boxplot of the Firmicutes-to-Bacteroidetes ratio of O/O and C children is presented. The ratio resulted in favour of the Firmicutes in O/O children and adolescents (p = 0.007).

![**Firmicutes-to-Bacteroidetes ratio of O/O versus C children.** O/O: obese group; C: control group. \*p = 0.007.](1757-4749-5-10-2){#F2}

Dietary assessment
------------------

The most important associations between analysed gut bacterial species, dietary compounds and energy intake in a subsample of 22 O/O and 25 C children are presented in Table  [2](#T2){ref-type="table"}. Children and adolescents with a high daily energy intake showed high faecal concentrations of *Staphylococcus* spp., analysed by means of quantitative plating (p = 0.028).

###### 

Most important associations between gut microbiota and dietary compounds represented by regression coefficient β (p value)

                                                       **Dietary compounds**                                                    
  --------------------------------------------------- ----------------------- ---------------- ---------------- --------------- -----------------
               **Quantitative plating**                                                                                                  
             *Bacteroides fragilis* group                  0.127 (0.110)       0.129 (0.129)    0.001 (0.987)                    −0.000 (0.620)
                *Bifidobacterium* spp.                    −0.025 (0.410)                                                          0.000 (0.822)
                  *Clostridium* spp.                                                                                              0.001 (0.156)
                 *Staphylococcus* spp.                                                                                           0.001 (0.028)\*
                 *Lactobacillus* spp.                      0.069 (0.360)       0.104 (0.180)                                             
                       **qPCR**                                                                                                          
      *Bacteroides-Prevotella-Porphyromonas* spp.          0.048 (0.319)       0.069 (0.220)                                     −0.000 (0.830)
                *Bifidobacterium* spp.                     0.017 (0.439)                                                          0.000 (0.285)
   *Clostridium coccoides-Eubacterium rectale* group                                                                              0.000 (0.269)
              *Clostridium leptum* group                                                                                          0.000 (0.240)
                 *Staphylococcus* spp.                    −0.093 (0.203)       −0.084 (0.285)   −0.083 (0.075)                    0.000 (0.691)
                 *Lactobacillus* spp.                      0.052 (0.503)       0.069 (0.401)    −0.000 (0.993)   0.010 (0.745)    0.000 (0.415)

Regression coefficient with 95% CI. \*Significant association with p value \< 0.05.

Biochemical markers
-------------------

Important biochemical markers were measured in fasting venous blood samples of 19 obese children (see Material and Method section for more details on blood sampling procedure). The following mean values were obtained: fasting plasma glucose: 82.44 ± 5.34 mg/dl; fasting plasma insulin: 21.58 ± 17.31 μU/ml; total cholesterol (TC): 176.26 ± 42.14 mg/dl; high-density lipoprotein (HDL) cholesterol: 49.61 ± 10.05 mg/dl; triglycerides (TG): 112.63 ± 81.92 mg/dl; leukocytes: 7.86 ± 2.42%; high-sensitive C-reactive protein (hs-CRP): 0.46 ± 0.36 mg/dl; alanin aminotransferase (ALT): 38.12 ± 19.82 U/l; aspartate aminotransferase (AST): 33.94 ± 12.79 U/l. The most important associations between major gut microbiota species and the concentration of the biochemical markers are presented in Table  [3](#T3){ref-type="table"}. Intestinal concentrations of *Lactobacillus* spp., which were analysed by quantitative plating, showed a positive association with plasma hs-CRP levels (p = 0.007).

###### 

Most important associations between biochemical parameters, gut microbiota and BMI SDS represented by regression coefficient β (p value)

                                                       **Biochemical markers**                                                                          
  --------------------------------------------------- ------------------------- --------- --------- --------- --------- --------- --------- ----------- --------
               **Quantitative plating**                                                                                                                     
             *Bacteroides fragilis* group                                        −1.469              −1.677              −6.926                             
                                                               (0.237)                     (0.099)             (0.497)                                  
                *Bifidobacterium* spp.                                            0.830                                   5.673    −1.619     −0.124        
                                                               (0.631)                                         (0.719)   (0.753)   (0.969)              
                  *Clostridium* spp.                           −0.276             0.071    −3.725               2.322    22.353               −3.598        
                        (0.562)                                (0.967)           (0.343)             (0.932)   (0.181)             (0.245)              
                 *Staphylococcus* spp.                                                                1.718    −30.933   −32.137                            
                                                                                           (0.414)   (0.381)   (0.122)                                  
                 *Lactobacillus* spp.                                                       2.040                                                        0.171
                                                                                 (0.497)                                                     (0.007)\*  
                       **qPCR**                                                                                                                             
      *Bacteroides-Prevotella-Porphyromonas* spp.                                                    −0.668                                                 
                                                                                           (0.771)                                                      
                *Bifidobacterium* spp.                                                                                                                      
   *Clostridium coccoides-Eubacterium rectale* group            0.860             0.825               1.259              33.654    −3.686     −6.465     0.285
                        (0.107)                                (0.810)                     (0.688)             (0.234)   (0.518)   (0.189)    (0.292)   
              *Clostridium leptum* group                                                                                                                    
                 *Staphylococcus* spp.                                                                         11.856                                       
                                                                                                     (0.481)                                            
                 *Lactobacillus* spp.                                            −1.307     1.342              17.604    −5.764                6.274     −0.004
                                                               (0.518)           (0.703)             (0.468)   (0.717)             (0.139)    (0.979)   
                      **BMI SDS**                               0.726             2.449     1.008     2.588    75.925    29.824    19.310     10.655     0.181
                        (0.469)                                (0.392)           (0.900)   (0.406)   (0.086)   (0.207)   (0.072)   (0.117)    (0.390)   

Regression coefficient with 95% CI. \*Significant association with p value \< 0.05.

Discussion
==========

At birth, the gut microbiota of an infant is sterile but rapidly assembles over days or months \[[@B20]\]. Mode of delivery (natural delivery versus caesarean section) and feeding method (breast feeding versus bottle feeding) have an early impact on the development of a child's gut microbiome \[[@B21]\]. At the age of four, the gut microbiota is fully mature \[[@B22]\]. Eventually, each person develops a unique gut microbiota which is stable over time in healthy adults \[[@B23]\].

In this cross-sectional study, the obese gut microbiota composition was compared with that of a lean one. We focused on two major phyla Bacteroidetes and Firmicutes, next to the *Bacteroides fragilis* group, *Bifidobacterium, Clostridium*, *Staphylococcus* and *Lactobacillus*. Different bacterial groups were selected according to the frequency to which they have been described in relevant literature \[[@B17]-[@B19],[@B24]\] and the ease of detection by the techniques used. On the one hand, quantitative plating was used as the 'gold standard' technique to isolate and characterise the selected bacterial groups. However, only 10 to 50% of all bacteria associated with the human body can be cultivated successfully \[[@B23],[@B25]\]. Subsequently, high-throughput culture-independent techniques, which use DNA sequences encoding the 16S ribosomal RNA subunit, were applied in order to assign an organism to a phylogenetic classification more accurately \[[@B25]\].

To our knowledge, our study was the first to perform an in-depth analysis of species belonging to the *Bacteroides fragilis* group by means of MALDI-TOF MS. Overall, our results reveal a high Firmicutes-to-Bacteroidetes ratio in faeces of obese children including alterations at species level.

Selective media have been used successfully to identify and enumerate *Bacteroides fragilis* group from human faeces \[[@B26]\]. For the first time, a further in-depth analysis of species of the *Bacteroides fragilis* group revealed reduced relative proportions of *B. vulgatus* in obese children and adolescents. One study reported decreased relative proportions of *B. vulgatus* in the faeces of type 2 diabetic subjects using species specific PCR-denaturing gradient gel electrophoresis (DGGE) \[[@B27]\]. *B. vulgatus* was found to constitute a part of the core gut microbiota in healthy humans and is generally considered to be a beneficial gut commensal \[[@B28]\]. These findings point towards a possible role for *B. vulgatus* in the pathophysiology of Western diseases, such as obesity and diabetes.

Moreover, the qPCR method that was used in this study to detect and quantify Bacteroidetes (*Bacteroides-Prevotella-Porphyromonas* spp.)*,* Firmicutes (*Clostridium coccoides-Eubacterium rectale* group*, Clostridium leptum* group*, Staphylococcus* spp. and *Lactobacillus* spp.), and *Bifidobacterium* spp. in human faeces has already been thoroughly evaluated and validated \[[@B29]-[@B31]\]. In agreement with the findings of previous studies \[[@B32],[@B33]\], we describe higher concentrations of *Lactobacillus* spp. in the obese gut microbiota. However, the use of quantitative plating did not permit the detection of a significantly higher concentration of *Lactobacillus* spp. in faeces of obese children, which we did see using qPCR. A possible explanation is that *L. gasseri* and *L. acidophilus* could not be identified in culture due to the presence of vancomycin in the LAMVAB medium \[[@B34]\]. Nevertheless, both quantitative culturing and qPCR resulted in a similar proportion of *Lactobacillus* spp. in the obese gut microbiota. A study conducted by Million et al. \[[@B32]\], demonstrated that *Lactobacillus reuteri* was associated with obesity in adults. By contrast, Santacruz et al. \[[@B33]\] showed that BMI SDS reduction in obese adolescents led to a concomitant increase in the concentrations of *Lactobacillus* spp. These findings thus suggest a possible role of *Lactobacillus* at species level in body weight and obesity. Additionally, we showed that the concentration of *Lactobacillus* spp. is positively correlated to plasma hs-CRP levels in obese children and adolescents. An increased prevalence of positive Firmicutes to higher levels of plasma hs-CRP was also seen in a study conducted in 51 obese and 28 normal-weight children and adults \[[@B35]\]. These results seems therefore to suggest a possible role for *Lactobacillus* spp. in "low-grade" inflammation, a major pathophysiological process of obesity.

Interestingly, we detected an elevated Firmicutes-to-Bacteroidetes ratio in the gut microbiota of obese children and adolescents. Previous investigators also showed significant associations between this ratio and obesity in mice and humans \[[@B11]-[@B14]\]. The results of our study are similar to a study in Spanish children, demonstrating increased concentrations of Firmicutes and decreased concentrations of Bacteroidetes in the obese gut \[[@B17]\]. Contrary to these findings, other studies described no or even opposite differences in the Firmicutes-to-Bacteroidetes ratio between obese and lean subjects \[[@B15],[@B16]\]. Possibly, these variations in study outcome are related to the fact that different methodologies were applied in these studies.

To further elucidate the complex role of gut microbiota in host physiology, a more thorough examination of the influence of diet on gut microbiota is recommended. In order to do so, we analysed the relationship between the presence of certain gut bacterial species with dietary compounds and energy intake. Here, we demonstrate that, independent of the BMI status, children and adolescents with a high energy intake (expressed in kcal/d) possess high faecal concentrations of *Staphylococcus* spp. analysed by quantitative culture. Note that the regression coefficient β of energy intake is low in all cases. This is due to the fact that values of energy intake are expressed in kcal/d. Given the range of energy intake (1635.53 to 2669.64 kcal), results in effect on mean concentration of *Staphylococcus* spp. of 1.27 to 2.08 are obtained. These results are not negligible and a real significant association has been detected. However, caution must be taken when translating these findings into a biological meaningful interpretation. Hence, more detailed research on this topic is necessary. Nevertheless, the importance of *Staphylococcus* spp. in childhood obesity has already been demonstrated by Kalliomaki et al. \[[@B24]\] who showed that a greater faecal concentration of *Staphylococcus* spp. during infancy predicted the development of overweight during childhood. A possible role of *Staphylococcus* spp. in energy harvesting during childhood is thus suggested.

One major limitation of the current study is the small sample size and therefore these results should be interpreted with caution. In addition, pregnancy related factors, social status, and the period of being obese prior to inclusion were not taken into account.

Further longitudinal research on the cause-effect relationship between gut microbiota and obesity is highly justified, since different bacterial species could play a significant role in the human energy harvest and weight regulation. Moreover, consideration of lifestyle factors in gut microbiota studies is highly recommended, since changes in dietary pattern and physical activity could influence gut microbiota composition and the development of obesity. Finally, we suggest to focus future research not only on the elucidation of gut microbiota composition in obese subjects, but also on the study of gut metabolites, i.e. "metabolomics". This suggestion for future research aims at expanding our knowledge on the complex interplay between gut microbiota, energy homeostasis and obesity.

In the future, modification of the gut microbiota composition by the administration of pro-, pre- or synbiotics in early childhood could offer an opportunity to prevent and/or treat obesity \[[@B36]\]. However, additional research is required.

Conclusions
===========

In this study, important compositional differences in the faecal gut microbiota of obese and lean children were revealed. This was generally reflected by an elevated Firmicutes-to-Bacteroidetes ratio in the obese study population. At the species level, low proportions of *B. vulgatus* and high concentrations of *Lactobacillus* spp. were found in faeces of obese children and adolescents. Furthermore, the presence of *Lactobacillus* spp. in the obese gut microbiota was positively associated with plasma hs-CRP levels. We also found a positive association between energy intake and the presence of *Staphylococcus* spp. in faeces of children, independent of their BMI status. The aforementioned bacterial genera and species may thus be more efficient at extracting energy from a given diet in obese children and adolescents compared with gut microbiota of lean children. Hence, *B. fragilis* group, *Lactobacillus* spp. and *Staphylococcus* spp. play an important role in the pathophysiology of childhood obesity. We hypothesize that an aberrant gut microbiota composition in combination with influences of lifestyle factors might contribute to the development of childhood obesity. To further confirm this hypothesis, additional research is required in a longitudinal setting with recruitment of a larger sample population. Finally, prevention and treatment strategies based on modification of the gut microbiota in obese children might conceivably contribute to limit the development of future obesity.

Methods
=======

Subject characteristics
-----------------------

Overweight, obese and morbidly obese (O/O: obese group) children were recruited from the paediatric obesity clinic at the Antwerp University Hospital. Normal-weight and lean children (C: control group) were recruited among the offspring of personnel working at the University of Antwerp. Skilled personnel recorded weight (scale, SECA 701 scale, Hamburg, Germany) and height (stadiometer, SECA 225, Hamburg, Germany) measurements, to the nearest 0.1 kg for weight and 1 mm for height and the BMI (in kg/m^2^). All subjects were classified based on the international BMI cut-off values of the Extended International Obesity Task Force (IOTF) for children aged 2 to 18 \[[@B37]\]. These values are based on age and gender-specific centile curves passing through BMI 35 (morbid obesity), 30 (obesity), 25 (overweight) and 18.5, 17 and 16 (thinness grades I, II and III) at age 18. BMI standard deviation score (SDS) was assessed using an electronic calculator (Auxology 1.1, Pfizer, New York, USA) based on the local reference standards, i.e. Flemish growth charts \[[@B38]\]. Exclusion criteria included the use of corticosteroids or antibiotics in the month prior to the study as well as during the study and significant co-morbidities such as an acute infection, prematurity or chronic diseases. The study was conducted in accordance with the ethical rules of the Helsinki Declaration. Informed consent was obtained from all children and their parents or legal guardian. The study protocol was approved by the local medical Ethics Committee of the Antwerp University Hospital (document 7/41/226).

Gut microbiota analyses
-----------------------

### Faecal sample collection

A fresh faecal sample was self-collected and stored immediately at −20°C. The collection took place in the same week as the dietary record. Subsequently, the faecal samples were transported to the laboratory and stored at −80°C until further analysis.

### Quantitative plating

Approximately 0.5 g of wet faeces was diluted in 9 volumes of phosphate buffer saline (PBS) and homogenized using a stomacher (Minimix®, Interscience, Arpents, France). Serial dilutions were plated using the Eddy Jet® apparatus (Led Techno, Heusden-Zolder, Belgium) onto the selective growth media. More specifically, *Staphylococcus* spp. were cultivated on mannitol salt agar (MSA) (Becton-Dickinson, Erembodegem, Belgium); only yellow and white colonies were considered \[[@B39]\]. *Bacteroides fragilis* group was determined on *Bacteroides* Bile Esculin agar (BBE) (Becton-Dickinson, Erembodegem, Belgium); only black pigmented colonies were considered \[[@B40]\]. *Clostridium* spp. counts were obtained after pre-treatment of the faecal sample in 70% ethanol for 30 minutes and subsequent culture on Columbia blood agar (CBA) \[[@B41]\]. *Lactobacillus* spp. were cultured on *Lactobacillus* anaerobic de Man, Rogosa and Sharpe with vancomycin and bromocresolgreen (LAMVAB) medium; only green and white colonies were considered \[[@B34]\]. *Bifidobacterium* spp. were determined on modified trypticase-phytone-yeast agar (MTPY); only colonies smaller than 0.7 mm were considered \[[@B42]\]. To confirm the presence of *Bifidobacterium* spp. in these colonies, a gram stain was conducted. The numbers of colonies positive for gram stain were expressed relative to the total number of colonies examined.

### MALDI-TOF MS analysis

Of each sample, ten presumed colonies of *Bacteroides fragilis* group were subcultured on Wilkins-Chalgren medium for 24h and spotted onto a target plate. Matrix-assisted laser desorption/ionization mass spectrometry (MALDI-TOF MS) analysis was accomplished according to the manufacturer's instructions (Microflex™ LT Bruker Daltonik GmbH, Bremen, Germany). Recorded mass spectra generated with the MALDI Biotyper 2.0 software package were compared with each entry of the MALDI Biotyper database and relationships were identified. According to the criteria by Nagy et al. \[[@B26]\], only identifications with a log (score) between 1.9 and 3.0 were considered to be significant and allowed for identification of the bacterial populations at the species level.

### Quantitative real-time PCR

#### DNA extraction

An aliquot (200 μl) of faecal suspension was suspended in 300 μl Tris-SDS solvent, 300 μg glass beads (diameter, 0.1 mm) and 500 μl TE-saturated phenol. Further extraction of total bacterial DNA was performed as described by Matsuki et al. \[[@B30]\]. The mixture was vortexed vigorously with FastPrep® FP120A (BIO 101® Systems, Thermo Scientific) for 30 s at a power level of 5.0. After centrifugation for 5 min at 13 000 rpm, 400 μl of the supernatant was collected and 400 μl phenol/chloroform/isoamylalcohol (25:24:1) was added. Subsequently, 250 μl of the supernatant was subjected to isopropanol.

#### qPCR

qPCR assay was performed as previously described by Rinttilä et al. \[[@B31]\]. All PCR experiments were carried out in triplicate with a reaction volume of 25 μl. The reaction mixture contained 7.5 μl sterile Milli-Q; 12.5 μl iQ SYBR Green Supermix and 1.25 μl of 10 μM of each primer (forward and reverse). Subsequently, 2.5 μl of faecal DNA was added to the reaction mixture. For each bacterial strain, positive controls were added to each reaction and the total bacterial copy number per organism was determined with 16S rRNA gene targeted primers \[[@B29]-[@B31]\]. The bacterial primer sequences are reported in Table  [4](#T4){ref-type="table"}.

###### 

16S rRNA gene-targeted group specific primers per bacterial group/species used in this study

                                   **Target**                                    **Primer sequence (5'-3')**              **Reference strains**              **Annealing temp (°C)**   **Reference**
  ----------------------------------------------------------------------------- ----------------------------- --------------------------------------------- ------------------------- ---------------
                                **Bacteroidetes**                                                                                                                                             
                   *Bacteroides-Prevotella-Porphyromonas* spp.                      GGTGTCGGCTTAAGTGCCAT        *Bacteroides fragilis* DSM 2151/LMG 10263              68               \[[@B31]\]
                             CGGA(C/T)GTAAGGGCCGTGC                                                                                                                                   
                                 **Firmicutes**                                                                                                                                               
                              *Staphylococcus* spp.                                  GCGATTGATGGTGATACG            *Staphylococcus aureus* ATCC 29213                  55               \[[@B29]\]
                                                                                  AGCCAAGCCTTFACGAACTAAAGC                                                                                    
   *Clostridium coccoides-Eubacterium* rectale group (clostridial cluster XIV)       CGGTACCTGACTAAGAAGC       *Ruminococcus productus* DSM 2950/YIT 6141              55               \[[@B31]\]
                                                                                   AGTTT(C/T)ATTCTTGCGAACG                                                                                    
                   *C. leptum* group (clostridial cluster IV)                         GCACAAGCAGTGGAGT           *Faecalibacterium prausnitzii* YIT 6174               50               \[[@B30]\]
                                                                                      TTCCTCCGTTTTGTCAA                                                                                       
                              *Lactobacillus* spp.                                   AGCAGTAGGGAATCTTCCA          *Lactobacillus acidophilus* LMG 9433                 58               \[[@B31]\]
                                                                                      CACCGCTACACATGGAG                                                                                       
                               **Actinobacteria**                                                                                                                                             
                             *Bifidobacterium* spp.                                TCGCGTC(C/T)GGTGTGAAAG      *Bifidobacterium longum* DSM 20219/YIT 4021             58               \[[@B31]\]
                              CCACATCCAGC(A/G)TCCAC                                                                                                                                   

#### The Firmicutes-to-Bacteroidetes ratio

An estimation of the total amount of Firmicutes was obtained by adding bacterial values (in log~10~ cells/g faeces) from *Clostridium coccoides-Eubacterium* rectale group (clostridial cluster XIV).

*Clostridium leptum* group (clostridial cluster IV), *Lactobacillus* spp. and *Staphylococcus* spp. For the total amount of Bacteroidetes, the *Bacteroides-Prevotella-Porphyromonas* spp. were taken into consideration. The ratio was calculated according to Mariat et al. \[[@B43]\].

Dietary assessment
------------------

A total of 22 (84.6%) O/O and 25 (92.6%) C children fully completed a five-day dietary record (three weekdays and two weekend days). The average daily intake of energy and nutrients was calculated with the use of Becel Institute Nutritional Software program. The dietary variables examined in this study were carbohydrates (energy %), fat (energy %), protein (energy %), fibres (g/day), and total energy intake (kcal/day).

Biochemical analyses
--------------------

Blood sampling was initially conducted to detect associated metabolic and inflammatory complications in the O/O group. Since only 19 out of 26 fasting venous blood samples of obese children were available, results of only these samples were considered. Glucose, total cholesterol (TC), high-density lipoprotein cholesterol (HDL-C), triglycerides (TG), alanine aminotransferase (ALT), aspartate aminotransferase (AST) and high-sensitive C-reactive protein (hs-CRP) were measured on Dimension Vista 1500 System (Siemens Healthcare Diagnostics Inc., Neward, Delaware, USA). Insulin levels were measured using chemoluminescence (Roche Diagnostics, Rotkreuz, Switzerland). White blood cell count was performed using flow cytometry (Advia 2120, Siemens Healthcare Diagnostics Inc., Neward, Delaware, USA).

Statistical analysis
--------------------

Descriptive and comparative analyses were performed in IBM SPSS version 20.0 (SPSS Inc., Chicago, IL, USA). The distribution of the residuals was tested for normality using the Kolmogorov-Smirnov test with Lilliefors correction. Independent samples *t* test was used in case of no significant deviation from normality. Otherwise the Mann Whitney *U* test was used. Chi square (*χ*^2^) test of association was used to compare characteristics between the O/O and C study groups. Data were presented as mean with standard deviation (mean ± SD) unless indicated otherwise. Since bacterial counts followed a right-skewed distribution, data were log~10~-transformed. Bacterial data were expressed as median log~10~ cells/g of faeces with interquartile ranges (IQR). Regression analyses were implemented in R 2.13.1. Explanatory variables were selected on the basis of a random forest analysis, i.e. a nonparametric technique that facilitates the selection of the important variables in a regression setting \[[@B44]\]. Given the random forest variable importance plot, the most important predictors above a visually selected cut-off value were chosen. Subsequently, multiple linear regression was applied to quantify the associations between gut microbiota, diet, biochemical parameters and BMI SDS controlled for age and gender. Wilcoxon-signed rank test was used to evaluate the difference of accuracy between quantitative culturing and qPCR. Statistical significance was assessed at the 5% level.
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